Over 100 Companies Set To Announce Q4FY26 Earnings Today: Key Stocks In Focus

India Inc. is gearing up for one of the busiest earnings days of the season, with more than 100 companies scheduled to announce their Q4FY26 results on May 12. The lineup includes major names across electronics manufacturing, power, pharma, fintech, gaming, consumer goods, and travel sectors.

Among the most closely watched companies today are Dixon Technologies, Tata Power, One MobiKwik Systems, Dr. Reddy's Laboratories, Pfizer, Nazara Technologies, Thomas Cook (India), and Torrent Power.

Why Today’s Earnings Matter

This earnings cycle comes at a crucial time for the market as investors closely track:

● Consumer demand trends

● Manufacturing growth momentum

● Power sector expansion

● Healthcare and pharma resilience

● Fintech profitability and cash flow

● Margin improvement across sectors

Several companies are also expected to announce dividends, management commentary, and forward-looking guidance that could influence market sentiment in the coming sessions.

Key Companies Investors Are Watching

Dixon Technologies

Dixon Technologies continues to remain one of the biggest beneficiaries of India’s electronics manufacturing push.

Its Q3FY26 performance highlighted strong operational efficiency:

● Revenue stood at Rs 10,803 crore

● EBITDA jumped 37% YoY to Rs 546 crore

● EBITDA margin expanded to 5.1%

● PAT surged 67% YoY to Rs 287 crore

With increasing focus on electronics exports and contract manufacturing, investors will closely monitor management commentary around growth visibility and margin sustainability.

Tata Power

Tata Power remains in focus amid India’s accelerating renewable energy transition.

In Q3FY26:

● PAT came in at Rs 1,194 crore

● EBITDA rose 12% YoY to Rs 3,919 crore

● Revenue declined 4% YoY to Rs 14,485 crore

Markets will watch for updates on renewable capacity expansion, transmission projects, and EV infrastructure growth.

Pfizer

Pfizer delivered a strong margin-led quarter in Q3FY26:

● Revenue rose 20% YoY to Rs 645 crore

● Net profit increased to Rs 142 crore

● Operating margin improved sharply to 35.4%

The pharma sector has remained relatively defensive, and investors will be keen to assess future product growth and profitability trends.

Broader Market Sentiment

Today’s earnings announcements could set the tone for sector-specific momentum across the Indian stock market. Strong guidance or positive surprises from large-cap and mid-cap names may influence institutional flows and retail investor sentiment in the near term.

With volatility expected around result announcements, traders and long-term investors alike will be closely tracking management commentary, margins, and future growth outlooks.